Insights on Longevity & Healthspan

27 total results. Page 2 of 2.

Alerts
FDA Announces End to Semaglutide Shortage, Impacting Compounders and Telehealth Providers Offering Injectable GLP-1 Drugs
Emily M. Cowley, Gayland O. Hethcoat II

Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a popular glucagon-like peptide 1 (GLP-1) weight loss and diabetes medication.

Alerts
California and Colorado Establish Protections for Neural Data
Michelle R. Bowling, D. Reed Freeman Jr.

When one hears the term “neural data,” a brain implant comes to mind, alongside concerns about these neurotechnologies being able to read our innermost thoughts.